3552-33-8 Usage
Description
2,5-Furandione,3-ethyl-4-methyl-, also known as 3-ethyl-4-methylfuran-2,5-dione, is an organic compound belonging to the class of furan-2,5-diones. It is characterized by its unique chemical structure, which consists of a furan ring with a dione group at the 2,5-positions, an ethyl group at the 3-position, and a methyl group at the 4-position. 2,5-Furandione,3-ethyl-4-methylis known for its various biological activities and potential applications in different industries.
Uses
Used in Pharmaceutical Industry:
2,5-Furandione,3-ethyl-4-methylis used as a bioactive ingredient in the pharmaceutical industry for its antimicrobial properties. It has demonstrated significant antimicrobial activity against various strains of bacteria, fungi, and yeast, making it a promising candidate for the development of new antimicrobial agents.
Used in Antimicrobial Applications:
2,5-Furandione,3-ethyl-4-methylis used as an antimicrobial agent for its effectiveness against a wide range of microorganisms, including Staphylococcus aureus (ATCC 6538), Escherichia coli (ATCC 18739), Listeria monocytogenes (ATCC 9610), Candida albicans (ATCC 13803), Candida tropicalis (LM 37), Candida guilliermondii (LM V70), and Aspergillus flavus (LM 247). Its broad-spectrum antimicrobial activity makes it a valuable compound for the development of new treatments and preventive measures against various infections.
Used in Essential Oils:
2,5-Furandione,3-ethyl-4-methylis found as one of the bioactive ingredients in the essential oil of the leaves of Maytenus obtusifolia (Celastraceae). This essential oil has shown significant antimicrobial activity, making it a valuable resource for the development of natural antimicrobial products and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 3552-33-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,5,5 and 2 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 3552-33:
(6*3)+(5*5)+(4*5)+(3*2)+(2*3)+(1*3)=78
78 % 10 = 8
So 3552-33-8 is a valid CAS Registry Number.
InChI:InChI=1/C7H8O3/c1-3-5-4(2)6(8)10-7(5)9/h3H2,1-2H3
3552-33-8Relevant articles and documents
Synthesis of the disubstituted maleic anhydride frame using a novel tandem radical-polar reaction
Pattarozzi, Mariella,Ghelfi, Franco,Roncaglia, Fabrizio,Pagnoni, Ugo M.,Parsonsb, Andrew F.
, p. 2172 - 2176 (2009)
An unreported 5-endo-trig atom-transfer radical cyclization of cyclic N-α-dichloroacyl-ketene-N,S-acetals, which evolves as a tandem radical-polar process, is described. The reaction, which is carried out in the presence of a Cu(I) complex catalyst (10 mol%) and an inorganic base (i.e., carbonate), can be exploited as the key step for a novel, short, and versatile synthesis of the 3,4-disubstituted maleic anhydride nucleus. Georg Thieme Verlag Stuttgart.
Preparation method of 2-methyl-3-ethyl maleic amide
-
Paragraph 0075; 0076; 0077; 0078; 0079; 0135; 0136-0139, (2017/08/29)
The invention relates to a preparation method of 2-methyl-3-ethyl maleic amide. The method comprises the following steps: preparing dimethyl maleic anhydride; preparing 2-methyl-3-ethyl maleic anhydride; and preparing 2-methyl-3-ethyl maleic amide. A process route develops a synthetic method of a series of maleimide and maleic anhydride, and meanwhile, a flavoring application experiment is performed on the series of precursor-aroma compounds, thereby providing an important support for developing novel perfume materials.
Compounds with anti-cancer activity
-
Page/Page column 85, (2008/12/08)
Novel substituted azole diones are provided that kill cells, suppress cell proliferation, suppress cell growth, abrogate the cell cycle G2 checkpoint and/or cause adaptation to G2 cell cycle arrest. Methods of making and using the invention compounds are provided. The invention provides substituted azole diones to treat cell proliferation disorders. The invention includes the use of substituted azole diones to selectively kill or suppress cancer cells without additional anti-cancer treatment. The invention includes the use of cell cycle G2-checkpoint-abrogating substituted azole diones to selectively sensitize cancer cells to DNA damaging reagents, treatments and/or other types of anti-cancer reagents.
